Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
CLRO Stock — ClearOne Inc
ClearOne Inc (CLRO)
Updated October 16, 2026.
CLRO is a Stock. Its deepest 1-year drawdown was 78.4%.
ClearOne Inc is a technology company incorporated in 1983 and headquartered in Salt Lake City, Utah; it previously designed and marketed professional audio conferencing, microphone, and video collaboration solutions but does not currently have significant operations. The company does not currently distribute to shareholders. This security may appeal to investors interested in turnaround situations or special situations where the company's assets or strategic direction may change.
CLRO dividend yield and income
Price as of 2026-10-16.
The ex-dividend date is 04/11/2024.
| Ex-date | As paid | Per current share | Change from previous payment |
|---|---|---|---|
| 2024-04-11 | $0.5 | $7.5 | -50.0% Unclassified cash |
| 2023-06-01 | $1 | $15 | 1328.6% Unclassified cash |
| 2018-03-06 | $0.07 | $1.05 | 0.0% Unclassified cash |
| 2017-11-21 | $0.07 | $1.05 | 0.0% Unclassified cash |
| 2017-08-18 | $0.07 | $1.05 | 0.0% Unclassified cash |
| 2017-05-15 | $0.07 | $1.05 | 40.0% Unclassified cash |
| 2017-02-13 | $0.05 | $0.75 | 0.0% Unclassified cash |
| 2016-11-14 | $0.05 | $0.75 | 0.0% Unclassified cash |
| 2016-08-15 | $0.05 | $0.75 | 0.0% Unclassified cash |
| 2016-05-27 | $0.05 | $0.75 | 0.0% Unclassified cash |
| 2016-03-03 | $0.05 | $0.75 | N/A |
| 2015-12-02 | $0.05 | $0.75 | N/A |
| 2015-11-02 | $0.035 | $0.525 | 0.0% Unclassified cash |
| 2015-07-23 | $0.035 | $0.525 | 0.0% Unclassified cash |
| 2015-04-30 | $0.035 | $0.525 | -65.0% Unclassified cash |
| 2014-12-10 | $0.1 | $1.5 | — |
| 2014 total | — | $1.5 | — |
| 2015 total | — | $2.325 | 55.0% |
| 2016 total | — | $3 | 29.0% |
| 2017 total | — | $3.9 | 30.0% |
| 2018 total | — | $1.05 | -73.1% |
| 2023 total | — | $15 | 1328.6% |
| 2024 total | — | $7.5 | -50.0% |
CLRO performance
Returns are updating. CLRO's total return appears here after the next nightly update.
Its deepest 1-year drawdown was 78.4%.
CLRO key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 03/03/1989
- Distribution frequency
- None
- 5-year average yield
- 2.18
- Last close
- $2.99 (as of 2026-10-16)
- Market cap
- $7,999,482
- Average volume
- 27454.0
- Ex-dividend date
- 04/11/2024
- Beta
- 0.186
- Payout ratio
- 0.0%
- Forward P/E
- 123.4568
- EPS
- $-1.90
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
CLRO risks and drawbacks
The deepest 1-year drawdown on record here is 78.4%.
Who may consider CLRO — and who may not
It is a weaker fit for investors who need monthly cash flow (CLRO does not currently distribute). This is educational context, not a recommendation to buy or sell.
More on CLRO
Frequently asked questions
Does CLRO pay monthly?
No. CLRO does not currently distribute.
When does CLRO pay a dividend?
CLRO does not currently distribute. The ex-dividend date is 04/11/2024.
How has CLRO performed?
Its deepest 1-year drawdown was 78.4%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.